Cargando…

Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/Nanoparticles

Coronavirus disease 2019 (COVID-19) has caused a global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The viral infection is reliant upon the binding between angiotensin-converting enzyme 2 receptor (ACE2) and spike protein (S). Therefore, ACE2 is a key receptor for SARS-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkhaldi, Soha Y., Peng, Ian, Peng, Ching-An
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294827/ https://www.ncbi.nlm.nih.gov/pubmed/37370582 http://dx.doi.org/10.3390/bioengineering10060652

Ejemplares similares

Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2
por: Zhang, Yongjing, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
por: Lei, Changhai, et al.
Publicado: (2020)

Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein
por: Johnson, Marc C., et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus
por: Wang, Nan, et al.
Publicado: (2020)

GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus
por: Yeh, Hsin, et al.
Publicado: (2022)

Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus
por: Fu, Xinping, et al.
Publicado: (2020)

Construction of SARS-CoV-2 spike-pseudotyped retroviral vector inducing syncytia formation
por: Lee, Se Yeong, et al.
Publicado: (2022)

Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions
por: Zheng, Yue, et al.
Publicado: (2020)

Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
por: Zheng, Yue, et al.
Publicado: (2021)

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
por: Crawford, Katharine H. D., et al.
Publicado: (2020)

Testing of the inhibitory effects of loratadine and desloratadine on SARS-CoV-2 spike pseudotyped virus viropexis
por: Hou, Yajing, et al.
Publicado: (2021)

Unique Aggregation of Retroviral Particles Pseudotyped with the Delta Variant SARS-CoV-2 Spike Protein
por: Petersen, Jennifer D., et al.
Publicado: (2022)

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
por: Bauer, Magnus S., et al.
Publicado: (2022)

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
por: Bauer, Magnus S., et al.
Publicado: (2022)

The Delta variant SARS-CoV-2 spike protein uniquely promotes aggregation of pseudotyped viral particles
por: Petersen, Jennifer D., et al.
Publicado: (2022)

Protocol to evaluate the inflammatory response in human macrophages induced by SARS-CoV-2 spike-pseudotyped VLPs
por: Ouyang, Maggie Jing, et al.
Publicado: (2023)

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays
por: Hyseni, Inesa, et al.
Publicado: (2020)

Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein
por: Tandon, Ritesh, et al.
Publicado: (2020)

Diminution of Phagocytosed Micro/Nanoparticles by Tethering with Immunoregulatory CD200 Protein
por: Zhang, Jun, et al.
Publicado: (2020)

SARS-CoV-2 spike and ACE2 entanglement-like binding
por: Pregnolato, Massimo, et al.
Publicado: (2023)

Silver nanoparticles with excellent biocompatibility block pseudotyped SARS-CoV-2 in the presence of lung surfactant
por: Gupta, Govind, et al.
Publicado: (2022)

The role of pseudotype neutralization assays in understanding SARS CoV-2
por: Cantoni, Diego, et al.
Publicado: (2021)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models
por: Wang, Gan, et al.
Publicado: (2020)

Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity
por: Diomede, Luisa, et al.
Publicado: (2021)

An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
por: Grehan, K., et al.
Publicado: (2015)

Bromelain inhibits SARS‐CoV‐2 infection via targeting ACE‐2, TMPRSS2, and spike protein
por: Sagar, Satish, et al.
Publicado: (2021)

Pseudotyped Vesicular Stomatitis Virus for Functional Analysis of Sars Coronavirus Spike Protein
por: Fukushi, Shuetsu, et al.
Publicado: (2006)

Efficient disinfection of SARS-CoV-2-like coronavirus, pseudotyped SARS-CoV-2 and other coronaviruses using cold plasma induces spike protein damage
por: Qin, Hongbo, et al.
Publicado: (2022)

Revealing the Mechanism of SARS-CoV-2 Spike Protein Binding With ACE2
Publicado: (2020)

SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex
por: Vásquez, Viviana, et al.
Publicado: (2022)

Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
por: Wrobel, Antoni G.
Publicado: (2023)

Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2
por: Bastos, Ruan S., et al.
Publicado: (2023)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding
por: Scheiblhofer, Sandra, et al.
Publicado: (2021)

Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles
por: Hsieh, Miao-Hsi, et al.
Publicado: (2021)

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
por: Zhang, Li, et al.
Publicado: (2021)

Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations
por: Tsai, Ming-Shao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_32b53l2va5lr81unii7acv695e